Company: MIRA
Filing Date: 2025-08-08
Form Type: DEFM14A
Source: 0001641172-25-022816
Chunk: 7

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-08-08
Form: DEFM14A
Chunk 7
---
 OF THE MIRA VIRTUAL ANNUAL MEETING                                                                                                                                                                                                                             |     | 51 |
| PRINCIPAL STOCKHOLDERS OF MIRA PHARMACEUTICALS, INC.                                                                                                                                                                                                                                                            |     | 65 |
| FUTURE STOCKHOLDER PROPOSALS                                                                                                                                                                                                                                                                                    |     | 66 |
| AVAILABILITY OF ANNUAL REPORT ON FORM 10-K                                                                                                                                                                                                                                                                      |     | 66 |
| STOCKHOLDERS SHARING THE SAME LAST NAME AND ADDRESS                                                                                                                                                                                                                                                             |     | 67 |
| INFORMATION INCORPORATED BY REFERENCE                                                                                                                                                                                                                                                                           |     | 67 |
| WHERE YOU CAN FIND MORE INFORMATION                                                                                                                                                                                                                                                                             |     | 67 |

| i |

<div align='center'>QUESTIONS AND ANSWERS ABOUT THE ANNUAL MEETING AND THE MERGER</div>

The following section provides answers to frequently asked questions about MIRA Pharmaceuticals, Inc.’s (“MIRA”, or “the Company”) annual meeting of shareholders (the “Annual Meeting”) and more specifically, the proposed Merger. This section, however, provides only summary information. For a more complete response to these questions and for additional information, please refer to the cross-referenced sections.

Q: When and where is the MIRA Annual Meeting?

A:The MIRA Annual Meeting will be held exclusively online via live audio-only webcast at https://web.lumiconnect.com/241-211-965 (password: mira2025) .promptly at 10:00 A.M. Eastern Time. Please note that you will not be able to attend the MIRA Annual Meeting in person.

Q: Who is entitled to vote at the Annual Meeting?

A:The Board has fixed the close of business on July 21, 2025 as the record date (the “Record Date”) for a determination of the stockholders entitled to notice of, and to vote at, the Annual Meeting. As of the Record Date, there are 19,069,315 shares of Common Stock of the Company outstanding. Each share of the Common Stock represents one vote that may be voted on each matter that may come before the Annual Meeting.

Q: May I ask questions at the Annual Meeting?

A: Yes. We expect that most of our directors and executive officers will attend the Annual Meeting and may be available to answer questions and make a statement if they desire to do so. We will provide our stockholders the opportunity to ask questions and make statements. Instructions for submitting questions and making statements